Ann: Notice of Annual General Meeting/Proxy Form, page-154

I look at this slightly differently

I think our Covid test will open doors for us for future tests

But Eugeni as a "Platform" I think is slightly oversold (if this this possible if we haven't sold anything)

Customers will be getting the reader for free if they buy enough tests.

And Eugeni itself is really just a rebadged Axxin device , slightly modified (Toyota charading as a Lexus anyone )

And Abbot are also working with Axxin with their Reader as well .....

Selling a Sepsis Test for a Eugeni reader may be easier with the door opened by our Covid test , but If Abbot or anyone else develops a Better Test then our "Platform" will end up in the trash basket.

We need to develop THE BEST TEST POSSIBLE for each medical need as they will all be judged independently.

Covid is here right now and will be 5 year + opportunity so we need to take advantage.

It will provide cashflow to market our "forever tests" , SEPSIS , TROPONIN , etc etc

Let's hope all those scientists we have been hiring are hard at it !!